In this issue of Cell, Liu et al. (2018) report the birth of two healthy cloned macaque monkeys using fetal fibroblasts. By artificially enhancing the arsenal of epigenetic modifiers in the oocyte, the authors overcome the earliest roadblocks that take place during somatic cell nuclear transfer (SCNT).
Somatic cell nuclear transfer (SCNT) is a laboratory procedure used to clone animals. Although the steps involved may vary slightly among species, they have, for the most part, remained constant over the years. J.B. Gurdon, in 1962 , first described the use of SCNT in vertebrates, showing that the nuclei of intestinal epithelial cells can be reprogrammed by the cytosol of an enucleated egg (Gurdon, 1962) . The ''new'' embryonic nuclei then developed into seemingly normal tadpoles. Some 35 years later came the first mammal ever cloned from an adult somatic cell, and what worked for Dolly the sheep in 1997 worked for about 22 other species cloned over the subsequent two decades (Rodriguez-Osorio et al., 2012) , but it did not work for one. Despite concerted efforts by many talented scientific teams around the world, no monkeys had been cloned from somatic cells.
In this issue of Cell, Liu et al. (2018) report the birth of healthy cloned macaque monkeys using fetal fibroblasts. This new milestone is the product of subtle refinements of decades-old cloning protocols and the use of epigenetic modifiers designed to overcome the earliest roadblocks that take place during SCNT (Figure 1 ).
We already knew the key basic elements necessary to clone mammals using somatic cells. The nuclei of Sertoli and cumulus cells, among the most suitable for cloning, should be in the G1 or G0 stage of the cell cycle when cloning from cultured somatic cells (Campbell et al., 1996) . The recipient oocyte must be at metaphase II with high levels of maturation-promoting factor, which in turn will induce both the rapid breakdown of the nuclear envelope and chromatin condensation. It is better to leave the reconstructed egg untouched for a few hours before triggering the resumption of the cell cycle. A premature release of intracellular calcium will hinder proper nuclear reprogramming and embryonic development. Egg activation is best achieved when intracellular calcium release mimics the same pattern triggered by sperm. The completion of the second meiotic division must be avoided to maintain normal ploidy. Finally, the sooner a cloned embryo is transferred to the uterus of a surrogate mother, the better the chances of producing a healthy clone.
Despite knowing all of these imperatives and despite decades of success using assisted reproductive technologies with macaques, implementing SCNT in monkeys proved harder to crack.
Until recently, we lacked the tools to understand how an oocyte could handle a somatic cell nucleus. The assumption was that a cloned embryo should be identical, both epigenetically and transcriptionally, to a one-cell fertilized embryo.
An early sign that cloned embryos not be considered equivalent to fertilized ones came from the pioneering work of Latham's group when, in 2002, they showed that a culture medium tailored to the metabolic needs of an early SCNT embryo was better than, but quite unlike, a conventional embryo medium (Chung et al., 2002) .
In general terms, during the first few hours after the onset of embryonic development, both fertilized and SCNT embryos undergo similar chromatin remodeling processes-i.e., global DNA demethylation and histone acetylation. Transcriptionally, though, they are very distinctive entities. Cloned embryos have a large number of genes-thousands-that remain unchanged before and after the somatic cell's introduction into the egg (Vassena et al., 2007) . These ''reprogrammingresistant genes'' carry the somatic cell's epigenetic memory and are believed to be responsible for the demise of clones.
During the early 2000s, significant efforts were made to modify the chromatin of SCNT embryos using small molecules capable of inducing global DNA demethylation and histone acetylation. Results were encouraging. Could we really artificially enhance the developmental potential of cloned embryos? Indeed, Wakayama's and Tsunoda's laboratories showed in 2006 that adding trichostatin A (TSA), a global histone deacetylase inhibitor, to a culture medium for a few hours after introducing somatic nuclei could improve the efficiency of mouse cloning considerably (Kishigami et al., 2006; Rybouchkin et al., 2006) .
The Yi-Zhang laboratory used more targeted approaches. They showed that H3K9me3, a histone residue associated with gene silencing, constituted one of the main barriers to reprogramming. They went on to show that just injecting mRNA for the demethylase Kdm4d in one-cell SCNT embryos could reactivate thousands of reprogramming-resistant genes. Removing these methyl groups from H3K9 significantly increased the chances of producing healthy cloned mouse pups; using this technique when making cloned human embryos produced blastocysts at higher rates (Matoba et al., 2014; Chung et al., 2015) .
In their latest work, Liu et al. (2018) tailored the oocyte cytosol to the chromatin status of the incoming nucleus. They used TSA and Kdm4d mRNA for a short period of time after cell fusion. In doing so, they cloned two healthy cynomolgus monkeys from the same cell line of fetal fibroblasts. Under the same protocol, but using adult cumulus cells as nuclei donors, two infants were born alive; however, neither offspring survived past day three. Using SCNT to clone monkeys remains far less efficient than producing in vitro fertilization (IVF) embryos, but it seems likely that cloning adult monkeys will soon be realized. The implications of this work are self-evident. It will allow us to edit genes in cultured cells from which we can generate genetically identical monkeys. This will affect all models of Multiple attempts by different laboratories produced no cloned monkeys using the traditional protocol. In the new protocol, mRNA for Kmd4d, histone demethylase that removes both di-and trimethylated H3 Lys-9 residues, is injected 2 hr after oocyte activation. This is followed by 10 hr of incubation with Trichostatin A (TSA), which increases the levels of histone acetylation by inhibiting class I and II histone deacetylases. Acetylated histones have less binding affinity for DNA, making it more accessible to transcription factors. Two healthy cloned monkeys were obtained using the new protocol with fetal fibroblasts as nuclei donors.
human disease, however common or rare.
Some issues to keep in mind for further refinement should be mentioned. Will we find, as we have in human and animal studies, that the reproductive age of the donor female influences the outcome of the procedure? Is the superovulation protocol used important? Is the synchronization between the age of the embryo and the surrogate uterus a factor? Should the amount of TSA and Kdm4b, as well as the time of exposure, be adjusted depending on the donor cell used? What other epigenetic modifiers or upstream regulators can induce cell plasticity?
For decades, we knew that when an oocyte was removed from the donor female, we became its guardians. There was nothing we could do to improve its developmental potential. Our role was to do whatever micromanipulation was needed-IVF or SCNT-and be pleased if we could just maintain the quality of the egg, as it had never been taken from the donor female. Liu et al. (2018) used two epigenetic modifiers during a very small window of time in embryonic development, inducing a radical shift on the clone's fate. This should come as no surprise to researchers working on the developmental origins of disease, but for those trying to understand the molecular mechanisms of SCNT, our mission now is to explore how to make eggs better. A new era of custom-made oocytes has begun.
